A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy

NCT03771898 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Metachromatic Leukodystrophy (MLD)

Interventions

DRUG: SHP611

Sponsor

Shire

Collaborators

[object Object]